Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP801662.RAjdTXvsBACcqhRiwU9G3zO9dvlUbmDZ-psemSrg-tU3k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP801662.RAjdTXvsBACcqhRiwU9G3zO9dvlUbmDZ-psemSrg-tU3k130_assertion type Assertion NP801662.RAjdTXvsBACcqhRiwU9G3zO9dvlUbmDZ-psemSrg-tU3k130_head.
- NP801662.RAjdTXvsBACcqhRiwU9G3zO9dvlUbmDZ-psemSrg-tU3k130_assertion description "[Intratumor administration of IL4-PE has been initiated for the treatment of malignant astrocytoma in a phase I clinical trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801662.RAjdTXvsBACcqhRiwU9G3zO9dvlUbmDZ-psemSrg-tU3k130_provenance.
- NP801662.RAjdTXvsBACcqhRiwU9G3zO9dvlUbmDZ-psemSrg-tU3k130_assertion evidence source_evidence_literature NP801662.RAjdTXvsBACcqhRiwU9G3zO9dvlUbmDZ-psemSrg-tU3k130_provenance.
- NP801662.RAjdTXvsBACcqhRiwU9G3zO9dvlUbmDZ-psemSrg-tU3k130_assertion SIO_000772 10367674 NP801662.RAjdTXvsBACcqhRiwU9G3zO9dvlUbmDZ-psemSrg-tU3k130_provenance.
- NP801662.RAjdTXvsBACcqhRiwU9G3zO9dvlUbmDZ-psemSrg-tU3k130_assertion wasDerivedFrom befree-20140225 NP801662.RAjdTXvsBACcqhRiwU9G3zO9dvlUbmDZ-psemSrg-tU3k130_provenance.
- NP801662.RAjdTXvsBACcqhRiwU9G3zO9dvlUbmDZ-psemSrg-tU3k130_assertion wasGeneratedBy ECO_0000203 NP801662.RAjdTXvsBACcqhRiwU9G3zO9dvlUbmDZ-psemSrg-tU3k130_provenance.